Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Vical, Inc. (VICL) Starts Presentation at 25th Annual ROTH Conference

Vical researches and develops biopharmaceutical products based on the company’s patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company’s DNA delivery technology include DNA vaccines for infectious diseases or cancer; cancer immunotherapeutics; and cardiovascular therapies. The company is developing certain infectious disease vaccines and cancer therapeutics internally. For more information, visit the company’s Web site: http://www.vical.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *